A recent study found that General-Benefit may be negatively associated with non-adherence among 398 patients with epilepsy from the UK primary care population (adjusted OR, 0.92, 95% CI 0.63 to 1.34) 18 and this association was confirmed by our study with a borderline significant OR of 0.75 (95% CI 0.56 to 1.02).
← all excerpts
Beliefs about medicines and non-adherence in patients with stroke, diabetes mellitus and rheumatoid arthritis: a cross-sectional study in China.
1
—
—